User talk:Hazeltonla

[[adminhelp}}

I have drafted a bio for a living person - Clete Willems. I have disclosed that Clete's law firm will compensate me for doing so. I apologize if I'm not following the right protocol (I've read various help and instruction pages until I am blind)--I would like someone to review the article to ensure that it meets with Wikipedia criteria. Thank you! https://en.wikipedia.org/wiki/Draft:Clete_Willems

Speedy deletion nomination of Willems clete square.jpg

A tag has been placed on Willems clete square.jpg requesting that it be speedily deleted from Wikipedia. This has been done under section F3 of the criteria for speedy deletion, because it is a file licensed as "for non-commercial use only", "no derivative use", "for Wikipedia use only", or "used with permission"; and it has not been shown to comply with the limited standards for the use of non-free content. If you agree with the deletion, there is no need to do anything. If, however, you believe that this image may be retained on Wikipedia under one of the permitted conditions then:

• state clearly the source of the image. If it has been copied from elsewhere on the web you should provide links to: the image itself, the page which uses it and the page which contains the license conditions.
• add the relevant copyright tag and if necessary, a complete fair use rationale.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be deleted without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If the page is deleted, and you wish to retrieve the deleted material for future reference or improvement, then please contact the deleting administrator, or if you have already done so, you can place a request here. Hazeltonla (talk) 17:23, 15 March 2021 (UTC)

Welcome

Hello, Hazeltonla, and Welcome to Wikipedia!   

Welcome to Wikipedia! I hope you enjoy the encyclopedia and want to stay. As a first step, you may wish to read the Introduction.

If you have any questions, feel free to ask me at my talk page – I'm happy to help. Or, you can ask your question at the New contributors' help page.

---

Here are some more resources to help you as you explore and contribute to the world's largest encyclopedia...

Finding your way around:

• Table of contents / Department directory

• The Wikipedia Adventure (a tutorial orienting you with Wikipedia)
• The Signpost, our newspaper

Need help?

• Questions – a guide on where to ask questions
• Cheatsheet – quick reference on Wikipedia's mark-up codes
• Wikipedia's 5 pillars – an overview of Wikipedia's foundations

• Article wizard – a Wizard to help you create articles
• The simplified ruleset – a summary of Wikipedia's most important rules
• Guide to Wikipedia – a thorough step-by-step guide to Wikipedia

How you can help:

• Contributing to Wikipedia – a guide on how you can help

• Community portal – Wikipedia's hub of activity

Additional tips...

• Please sign your messages on talk pages with four tildes (~~~~). This will automatically insert your "signature" (your username and a date stamp). The or button, on the tool bar above Wikipedia's text editing window, also does this.
• If you would like to play around with your new Wiki skills without changing the mainspace, the Sandbox is for you.

Hazeltonla, good luck, and have fun. Aboutmovies (talk) 04:14, 27 June 2018 (UTC)

COI

Based on your edit history, edit summaries, and other information that cannot be mentioned here due to privacy rules, I am almost certain that you have a financial conflict of interest. You should probably disclose that. I am also open to the idea that I am mistaken. Feel free to correct me if that is the case. Lostinspacetime1949 (talk) 13:54, 23 May 2019 (UTC)

Disclosure required

Based on your lack of response to the message above, here is some more explicit directions ...

Hello Hazeltonla. The nature of your edits gives the impression you have an undisclosed financial stake in promoting a topic, but you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially egregious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to black-hat SEO.

Paid advocates are very strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists, and if it does not, from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:Hazeltonla. The template {{Paid}} can be used for this purpose – e.g. in the form: {{paid|user=Hazeltonla|employer=InsertName|client=InsertName}}. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, do not edit further until you answer this message. Peacock (talk) 13:47, 16 October 2019 (UTC)

Thank you for making me aware of this. I do not know how to respond to comments (meaning, where or how to post a response). I will update my page as has been suggested. I have been careful to make certain that any edits I have made have been factual and verifiable. I was not aware of the paid editing disclosure requirement, but I am now.Hazeltonla (talk) 20:12, 21 December 2019 (UTC)Hazeltonla

Orphaned non-free image File:Stoel Rives' New Logo.jpg

⚠

Thanks for uploading File:Stoel Rives' New Logo.jpg. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).

Note that any non-free images not used in any articles will be deleted after seven days, as described in section F5 of the criteria for speedy deletion. Thank you. --B-bot (talk) 19:35, 4 February 2020 (UTC)

Please see below regarding edits to Micheal J. Sofia's page, made at his request. Thanks

Hazeltonla (talk) 19:54, 1 May 2020 (UTC)

AfC

Hello, and thank you for your contributions to Wikipedia. A page you recently created may not conform to some of Wikipedia's guidelines for new pages, so it has been moved to where you can continue to work on it. Please consider using the Article Wizard or the Articles for Creation procedure. For more information about creating articles, you may want to read "Your first article". You may also want to read our introduction page to learn more about contributing. Thank you. HickoryOughtShirt?4 (talk) 00:01, 29 April 2020 (UTC)

As an editor with a disclosed conflict of interest, you should use Wikipedia's WP:AfC process. HickoryOughtShirt?4 (talk) 00:08, 29 April 2020 (UTC)

I previously edited Michael J. Sofia's page at his request, last October. A few days ago, all the changes I made at his request were obliterated and the article reverted to a prior, out of date version without a photo. Below are the changes I had made. You can see, I believe, that everything I wrote is factual and verifiable and most of it is sourced. Are these changes not permitted? Thanks

Collapsing for brevity
The following discussion has been closed. Please do not modify it.
Hazeltonla File:Micheal J. Sofia.jpg Born Baltimore, Maryland, United States Education Cornell University, B.A., Chemistry, with honors, 1980 University of Illinois Urbana-Champaign, 1984 NIH Postdoctoral Fellowship, Columbia University Known for The discovery and development of Sofosbuvir (Sovaldi®, Harvoni®, Epclusa®, & Vosevi®) as the backbone therapy for curing HCV. Awards Lasker-DeBakey Award in Clinical Medical Research, Innovation Award in Biosciences, The Economist, IUPAC-Richter Prize, International Union of Pure and Applied Chemistry, Medicinal Chemistry Hall of Fame Inductee, American Chemical Society Michael J. Sofia is an American scientist, professor, patent-holder, and author, known for inventing Sofosbuvir (Sovaldi®, Harvoni®, Epclusa®, & Vosevi®) for the treatment and cure of HCV infection. His primary research focus is on hepatitis C virus and hepatitis B virus drug discovery. In 2016, he was awarded the Lasker-DeBakey Clinical Medical Research Award for his research on hepatitis C, along with Charles M. Rice and Ralf F. W. Bartenschlager. He is the author or co-author of more than 109 scientific papers and reviews and the author of 13 book chapters. He is an inventor on more than 54 U.S. patents. Early Life and Education Sofia was born (1958) and raised in Baltimore, Maryland, and attended the Baltimore Polytechnic Institute High School. He obtained his B.A., cum laude, in Chemistry from Cornell University in 1980 and a Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign in 1984. He was an NIH Postdoctoral Fellow at Columbia University from 1984 to 1986. In 2011, he received a certificate in Pharmaceutical/Biotech Management from The Wharton School of the University of Pennsylvania. In 2019, the University of Messina, Italy, awarded him an Honorary Doctorate in Applied Biology and Experimental Therapeutics. Career Following his post-doctoral fellowship, Sofia joined E.R. Squibb, Squibb Institute for Medical Research, in June 1986 as a Research Scientist. In January 1989, Sofia joined Eli Lilly as a Senior Research Scientist in Lilly Research Labs, serving as a medicinal chemist and project leader in the area of anti-inflammatory diseases drug discovery and therapies for the treatment of asthma, inflammatory bowel disease, and psoriasis. In July 1993, he transitioned to Transcell Technologies / Intercardia Inc. where he served as the Director of Chemistry and later as the Vice President of Research. In those roles, he was responsible for the drug discovery efforts in the area of antibacterials and led the technology development in the areas of carbohydrate-based combinatorial chemistry and drug delivery. Sofia joined Bristol-Myers Squibb in June 1999 as the Group Director – New Leads Chemistry where he was responsible for global capabilities in lead generation, early lead optimization, natural products, and sample management. Sofia became the Senior Vice President – Chemistry for Pharmasset, Inc., in August 2005. At Pharmasset, he was responsible for drug discovery chemistry, process research, analytical, and computational chemistry functions, including programs for HCV, HIV, and HBV drug discovery and prodrug development efforts. He invented Sofosbuvir (PSI-7977, GS-7977), named for him and approved for the treatment and cure of hepatitis C. He led the discovery and early development teams for Sofosbuvir. Pharmasett was acquired by Gilead Sciences, Inc., and Sofia served as a member of the Gilead Senior Research Leadership Team. In July 2012, Sofia became the President, Chief Scientific Officer and co-founder of OnCore Biopharma, Inc., where he established the strategic direction of the company in hepatitis B. In the months leading up to March 2015, Sofia negotiated OnCore Biopharma’s strategic merger with Tekmira, a combination renamed Arbutus Biopharma, Inc. He continues to serve as the rechristened company’s Chief Scientific Officer, responsible for all discovery and preclinical research efforts. He is a member of Arbutus Biopharma’s corporate operating committee. Sofia has been an adjunct professor at Drexel University College of Medicine since March 2013, focused in the area of infectious disease drug discovery and development. He is also a professor at the Baruch S. Blumberg Institute, since April 2013, focused on the discovery of novel agents to treat liver diseases. Sofia is a member of the American Chemical Society and its Organic and Medicinal Chemistry Divisions. He is also a member of the American Association for the Advancement of Science, the International Society of Antiviral Research, the American Association for the Study of Liver Disease, and the European Association for the Study of Liver Disease. Sofia serves on the editorial boards for ACS Medicinal Chemistry Letters, ChemMedChem, and Infectious Disorders: Drug Targets. His extramural activities have included serving in the following capacities: Board of Trustees, University of the Sciences, Philadelphia, Pennsylvania (2016 – present) Chemical and Engineering News Advisory Board (2014 – present) Blumberg Institute Board of Directors (2014 – present) Honors and Awards Honorary Doctorate in Applied Biology and Experimental Therapeutics, University of Messina, Italy, 2019 Honorary Citizenship, Castroreale, Sicily, 2018 John Montgomery Award, International Society of Nucleosides, Nucleotides and Nucleic Acids, 2018 Humanitarian Award, Sons of Italy Foundation, 2018 Honorary Fellow, Foreign Policy Association, 2017 Science and Technology Medal, New Jersey Research and Development Council, 2017 Medicinal Chemistry Hall of Fame Inductee, American Chemical Society, 2017 Top 100 Power List of the Most Influential Individuals in Pharma, Medicine Maker, 2017 Gertrude Elion Memorial Award, International Society for Antiviral Research, 2017 Alumni Achievement Award, University of Illinois College of Arts and Sciences, 2017 Lasker-DeBakey Award in Clinical Medical Research, Lasker Foundation, 2016 IUPAC-Richter Prize, International Union of Pure and Applied Chemistry, 2016 Innovation Award in Biosciences, The Economist, 2015 Heroes of Chemistry Award, The American Chemical Society, 2015 100 Top Global Thinkers, Foreign Policy, 2014 Scientific Achievement Award, Life Sciences Pennsylvania (formerly, Pennsylvania Bio), 2014 Lilly Research Laboratories Discovery Team Award, 1991 Postdoctoral Fellowship, National Institutes of Health, 1984 – 1986 R. C. Fuson Memorial Award for Superior Performance in Graduate Research, 1984 Graduate Traineeship, National Institutes of Health, 1980 – 1984 Graduate Fellowship, University of Illinois, 1980 References

Hazeltonla (talk) 19:54, 1 May 2020 (UTC)

• I've collapsed your text, it isn't necessary to reproduce it here at all as it is stored in the article edit history. I've also removed the categories so this page is not categorized as an article. According to the article edit history, your changes were reverted as unsourced. If you have independent reliable sources for your edits, you should offer them- but as you have what we call a conflict of interest, you should avoid directly editing the article- instead, you may propose changes on the article talk page as a formal edit request(click for instructions) so that an impartial editor can review them. In addition if Sofia is compensating you in any way, you must make the Terms of Use required paid editing declaration. Please understand that Wikipedia articles are not for merely telling about a person and their accomplishments like a resume; Wikipedia articles should only summarize what independent reliable sources state about the subject. 331dot (talk) 20:55, 1 May 2020 (UTC)

Your submission at Articles for creation: Gina F. Rubel (May 1)

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by Sulfurboy were: Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.

• If you would like to continue working on the submission, go to Draft:Gina F. Rubel and click on the "Edit" tab at the top of the window.
• If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Gina F. Rubel, click on the "Edit" tab at the top of the window, add "{{Db-g7}}" at the top of the draft text and click the blue "publish changes" button to save this edit.
• If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
• If you need any assistance, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

Sulfurboy (talk) 19:18, 1 May 2020 (UTC)

Hello, Hazeltonla! Having an article declined at Articles for Creation can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! Sulfurboy (talk) 19:18, 1 May 2020 (UTC)

Your draft article, Draft:Gina F. Rubel

Hello, Hazeltonla. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Gina F. Rubel".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been nominated for deletion. If you plan on working on it further, or editing it to address the issues raised if it was declined, simply and remove the {{db-afc}}, {{db-draft}}, or {{db-g13}} code.

If your submission has already been deleted by the time you get there, and you wish to retrieve it, you can request its undeletion by following the instructions at this link. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thank you for your submission to Wikipedia! UnitedStatesian (talk) 20:50, 19 November 2020 (UTC)

Orphaned non-free image File:Willems clete square.jpg

⚠

Thanks for uploading File:Willems clete square.jpg. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).

Note that any non-free images not used in any articles will be deleted after seven days, as described in section F5 of the criteria for speedy deletion. Thank you. --B-bot (talk) 03:02, 17 March 2021 (UTC)

Your submission at Articles for creation: Clete Willems (July 11)

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by Goldsztajn were:  The comment the reviewer left was: Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.

• If you would like to continue working on the submission, go to Draft:Clete Willems and click on the "Edit" tab at the top of the window.
• If you now believe the draft cannot meet Wikipedia's standards or do not wish to progress it further, you may request deletion. Please go to Draft:Clete Willems, click on the "Edit" tab at the top of the window, add "{{Db-g7}}" at the top of the draft text and click the blue "publish changes" button to save this edit.
• If you do not make any further changes to your draft, in 6 months, it will be considered abandoned and may be deleted.
• If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the Articles for creation help desk, on the reviewer's talk page or use Wikipedia's real-time chat help from experienced editors.

Goldsztajn (talk) 13:59, 11 July 2021 (UTC)

Pat Lundvall - August 2021

Hello, Hazeltonla. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about on the page Pat Lundvall, you may have a conflict of interest (COI). Editors with a conflict of interest may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:

• avoid editing or creating articles about yourself, your family, friends, colleagues, company, organization or competitors;
• propose changes on the talk pages of affected articles (you can use the {{request edit}} template);
• disclose your conflict of interest when discussing affected articles (see Wikipedia:Conflict of interest#How to disclose a COI);
• avoid linking to your organization's website in other articles (see Wikipedia:Spam);
• do your best to comply with Wikipedia's content policies.

In addition, you are required by the Wikimedia Foundation's terms of use to disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation. See Wikipedia:Paid-contribution disclosure.

Also, editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. Thank you. The C of E God Save the Queen! (talk) 21:43, 11 August 2021 (UTC)

Concern regarding Draft:Clete Willems

Hello, Hazeltonla. This is a bot-delivered message letting you know that Draft:Clete Willems, a page you created, has not been edited in at least 5 months. Drafts that have not been edited for six months may be deleted, so if you wish to retain the page, please edit it again or request that it be moved to your userspace.

If the page has already been deleted, you can request it be undeleted so you can continue working on it.

Thank you for your submission to Wikipedia. FireflyBot (talk) 23:03, 2 August 2022 (UTC)

Your draft article, Draft:Clete Willems

Hello, Hazeltonla. It has been over six months since you last edited the Articles for Creation submission or draft page you started, "Clete Willems".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been nominated for deletion. If you plan on working on it further, or editing it to address the issues raised if it was declined, simply and remove the {{db-afc}}, {{db-draft}}, or {{db-g13}} code.

If your submission has already been deleted by the time you get there, and you wish to retrieve it, you can request its undeletion by following the instructions at this link. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thank you for your submission to Wikipedia! Hey man im josh (talk) 22:04, 2 September 2022 (UTC)